miR-26a-5p Protects Against Drug-induced Liver Injury via Targeting Bid

Pages: 1 - 27
Published: Nov 9, 2021
Abstract
miR-26a-5p is a short noncoding RNA that is abnormally expressed in drug-induced liver injury (DILI), but its pathophysiologic role in the mechanism of disease in DILI is still vague.The expression of miR-26a-5p, viability of hepatic stellate cells (HSCs) proliferation, and apoptosis were explored via real-time PCR, CCK-8 assay, Tunel fluorescence, and flow cytometry. The expression of Bid was detected via Western blot assays, real-time PCR, and...
Paper Details
Title
miR-26a-5p Protects Against Drug-induced Liver Injury via Targeting Bid
Published Date
Nov 9, 2021
Pages
1 - 27
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.